Literature DB >> 6408394

A high-spin form of cytochrome P-450 highly purified from polychlorinated biphenyl-treated rats. Catalytic characterization and immunochemical quantitation in liver microsomes.

T Kamataki, K Maeda, Y Yamazoe, N Matsuda, K Ishii, R Kato.   

Abstract

A high-spin form of cytochrome P-450 (termed PCB P-448-H) was purified from liver microsomes of polychlorinated biphenyl (PCB)-treated rats to homogeneity as judged by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. This high-spin form of cytochrome P-450 was distinguishable from a low-spin form of cytochrome P-450 (PCB P-448-L) purified from microsomes of PCB-treated rats by the criteria of molecular weights, peptide mapping, and immunochemical properties. In addition, PCB P-448-H catalyzed the hydroxylation of acetanilide (position 4) and biphenyl (positions 2 and 4), and N-hydroxylation of the promutagens 3-amino-1-methyl-5H-pyrido(4,3-b)indole (Trp-P-2), 2-amino-6-methyl-dipyrido(1,2-alpha:3',2'-d)imidazole (Glu-P-1), 2-aminofluorene, and 4-aminobiphenyl at much faster rates than did PCB P-448-L. These promutagens and aflatoxin B1 were efficiently metabolized to mutagens by this high-spin form of hemoprotein. Rabbit immunoglobulin G (IgG) raised against PCB P-448-H inhibited the microsomal O-depropylation activity of p-propoxyaniline. Radial immunodiffusion assay with the IgG showed that PCB P-448-H was one of the major forms of cytochrome P-450 in liver microsomes of PCB-treated rats. On the basis of these results, we propose that this high-spin form of cytochrome P-450 is a key enzyme activating a variety of environmental promutagens in the 9000 x g supernatant fraction of PCB-treated rats, which has been widely used as an activation system in routine mutation tests.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6408394

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  14 in total

1.  Induction of cytochrome P-450 isozymes upon repeated administration of nifedipine.

Authors:  M Koleva; T Stoytchev; L Gulyaeva; A Grishanova; V Mishin; V Lyakhovich
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Apr-Jun       Impact factor: 2.441

2.  Cell-specific induction of mouse Cyp1a1 mRNA during development.

Authors:  A Dey; H Westphal; D W Nebert
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

Review 3.  Zonation of hepatic cytochrome P-450 expression and regulation.

Authors:  T Oinonen; K O Lindros
Journal:  Biochem J       Date:  1998-01-01       Impact factor: 3.857

4.  Tissue-specific expression of the mouse dioxin-inducible P(1)450 and P(3)450 genes: differential transcriptional activation and mRNA stability in liver and extrahepatic tissues.

Authors:  S Kimura; F J Gonzalez; D W Nebert
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

5.  Structure-related inhibitory effect of antimicrobial enoxacin and derivatives on theophylline metabolism by rat liver microsomes.

Authors:  Y Mizuki; I Fujiwara; T Yamaguchi; Y Sekine
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

6.  Effects of lead on 4-aminobiphenyl pharmacokinetics in liver, kidney, spleen, testes, heart, lung and hemoglobin adduct for rat model.

Authors:  Hui-Ming Chen; Tao Qin; Li-Xin Zhao; Xiao-Bai Xu
Journal:  Ecotoxicology       Date:  2002-08       Impact factor: 2.823

7.  Detection of three genetic polymorphisms in the 5'-flanking region and intron 1 of human CYP1A2 in the Japanese population.

Authors:  M Chida; T Yokoi; T Fukui; M Kinoshita; J Yokota; T Kamataki
Journal:  Jpn J Cancer Res       Date:  1999-09

8.  Species difference among experimental rodents in the activity and induction of cytochrome P-450 isozymes for mutagenic activation of carcinogenic aromatic amines.

Authors:  M Degawa; T Agatsuma; Y Hashimoto
Journal:  Jpn J Cancer Res       Date:  1990-12

9.  Changes in the quantity and activity of cytochrome P-450 isozymes in primary cultured rat hepatocytes.

Authors:  M Namiki; M Degawa; T Masuko; Y Hashimoto
Journal:  Jpn J Cancer Res       Date:  1989-02

10.  Species difference among experimental rodents in induction of P450IA family enzymes by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.

Authors:  M Degawa; K Kobayashi; S Miura; H Arai; H Esumi; T Sugimura; Y Hashimoto
Journal:  Jpn J Cancer Res       Date:  1992-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.